NAD Keeps An Eye On Anti-Aging Claims With Olay Regenerist Inquiry
This article was originally published in The Rose Sheet
Executive Summary
The National Advertising Division of the Council of Better Business Bureaus recommended Procter & Gamble modify ads for Olay Regenerist Eye Lifting Serum that imply the product can produce results similar to eyelift surgery following a recent inquiry
You may also be interested in...
Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD
Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports
Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD
Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports
P&G Discontinues Olay Regenerist Ad With “Inadequate” Disclaimer
Procter & Gamble has permanently discontinued a print ad for Olay Regenerist Night following an inquiry by the National Advertising Division of the Council of Better Business Bureaus, the agency says in a recent Case Reports